Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1).
Schlessinger J, Shepard JS, Gower R, Su JC, Lynde C, Cha A, Ports WC, Purohit V, Takiya L, Werth JL, Zang C, Vlahos B; CARE 1 Investigators. Schlessinger J, et al. Among authors: cha a. Am J Clin Dermatol. 2020 Apr;21(2):275-284. doi: 10.1007/s40257-020-00510-6. Am J Clin Dermatol. 2020. PMID: 32212104 Free PMC article. Clinical Trial.
Response to the Letter to the Editor Regarding "Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systemic Literature Review and Network Meta-Analysis".
Fahrbach K, Tarpey J, Washington EB, Hughes R, Thom H, Neary MP, Cha A, Gerber R, Cappelleri JC. Fahrbach K, et al. Among authors: cha a. Dermatol Ther (Heidelb). 2021 Dec;11(6):2241-2244. doi: 10.1007/s13555-021-00608-7. Epub 2021 Oct 10. Dermatol Ther (Heidelb). 2021. PMID: 34628584 Free PMC article. No abstract available.
Matching-Adjusted Indirect Comparison of Crisaborole Ointment 2% vs. Topical Calcineurin Inhibitors in the Treatment of Patients with Mild-to-Moderate Atopic Dermatitis.
Thom H, Cheng V, Keeney E, Neary MP, Eccleston A, Zang C, Cappelleri JC, Cha A, Thyssen JP. Thom H, et al. Among authors: cha a. Dermatol Ther (Heidelb). 2022 Jan;12(1):185-194. doi: 10.1007/s13555-021-00646-1. Epub 2021 Dec 8. Dermatol Ther (Heidelb). 2022. PMID: 34877623 Free PMC article.
Validation of Patient Identification Algorithms for Atopic Dermatitis Using Healthcare Databases.
Ortsäter G, De Geer A, Geale K, Rieem Dun A, Lindberg I, Thyssen JP, von Kobyletzki L, Ballardini N, Henrohn D, Neregård P, Cha A, Cappelleri JC, Neary MP. Ortsäter G, et al. Among authors: cha a. Dermatol Ther (Heidelb). 2022 Feb;12(2):545-559. doi: 10.1007/s13555-021-00670-1. Epub 2022 Jan 18. Dermatol Ther (Heidelb). 2022. PMID: 35041157 Free PMC article.
142 results